CEA BINDING AGENTS TO REVERSE CEA-MEDIATED TUMORIGENIC EFFECTS ON HUMAN CANCER CELLS AND USES THEREOF

Details for Australian Patent Application No. 2003278002 (hide)

Owner MCGILL UNIVERISTY

Inventors STANNERS, Clifford, P.; ILANTZIS, Christian

Pub. Number AU-A-2003278002

PCT Number PCT/CA03/01533

PCT Pub. Number WO2004/031238

Priority 60/415,520 03.10.02 US

Filing date 3 October 2003

Wipo publication date 23 April 2004

International Classifications

C07K 016/00 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

26 February 2004 Complete Application Filed

  Priority application(s): 60/415,520 03.10.02 US

27 May 2004 Application Open to Public Inspection

  Published as AU-A-2003278002

14 July 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003278003-PHASOR FRAGMENTATION CIR- CUITRY AND METHOD FOR PROCESSING MODULATED SIGNALS HAVING NON-CONSTANT ENVELOPES

2003278001-METHOD FOR MAGNETRON SPUTTERING